Mea Kākau: Clyde Lopez
Lā O Ka Hana: 23 Iulai 2021
HōʻAno Hou I Ka Lā: 11 Mei 2025
Anonim
FDA Approval of Gamifant® (emapalumab-Iszg) for Primary HLH Treatment
Wikiō: FDA Approval of Gamifant® (emapalumab-Iszg) for Primary HLH Treatment

Anter

Hoʻohana ʻia ka hoʻopili ʻana o Emapalumab-lzsg e mālama i nā mākua a me nā keiki (hānau hou a me nā makahiki) me ka lymphohistiocytosis hemophagocytic mua (HLH; kahi ʻano hoʻoilina kahi e hana ʻole ai ka ʻōnaehana pale kino a hana i ka pehu a me ka hōʻino o ke ake, ka lolo, a me ka iwi o ka iwi) nona ka maʻi i hoʻomaikaʻi ʻole ʻia, hele a maikaʻi ʻole, a hoʻi mai paha ma hope o ka mālama mua ʻana a i ʻole hiki ʻole ke lawe i nā lāʻau ʻē aʻe. Aia ka hoʻopili ʻana o Emapalumab-lzsg i kahi papa lāʻau i kapa ʻia he monoclonal antibodies. Hana ia ma ke kāpae ʻana i ka hana o kekahi protein i loko o ka ʻōnaehana paleʻea e hoʻomaka ai ka wela.

Hele mai ʻo Emapalumab-lzsg me he wai lā e hoʻokomo ʻia i loko o kahi aa koko ma mua o 1 hola e ke kauka a kahu hānai paha i kahi haukapila a i ʻole kahi wahi olakino. Hāʻawi pinepine ʻia ia i 2 manawa i kēlā me kēia pule, i kēlā me kēia 3 a i ʻole 4 mau lā, no ka mea ke koi aku kāu kauka e loaʻa iā ʻoe ka lāʻau.

E hoʻomaka paha kāu kauka iā ʻoe ma kahi lāʻau haʻahaʻa o ka hoʻopili ʻana o emapalumab-lzsg a hoʻonui iki i kāu lāʻau, ʻaʻole ʻoi aku i hoʻokahi manawa i kēlā me kēia 3 mau lā.


Emapalumab-lzsg injection hiki ke hana i kahi hopena koʻikoʻi i ka wā a ma hope paha o ka hoʻokomo ʻia ʻana o ka lāʻau. E nānā pono kahi kauka a kahu hānai paha iā ʻoe ke loaʻa iā ʻoe ka lāʻau. Inā ʻoe e ʻike i kekahi o kēia mau ʻōuli, e haʻi koke aku i kāu kauka: ʻulaʻula o ka ʻili, ʻili, kuni, ʻeleu, sweating nui, anuanu, nausea, luaʻi, lightheadedness, dizziness, ʻeha o ka umauma, a me ka liʻiliʻi o ka hanu.

E hāʻawi aku kāu kauka a mea kauka paha iā ʻoe i ka palapala ʻike hoʻomanawanui o ka mea hana (Kauka Lapaʻau) ke hoʻomaka ʻoe i ka lāʻau me ka inikū emapalumab-lzsg a i kēlā me kēia manawa ke loaʻa iā ʻoe ka lāʻau. E heluhelu pono i ka ʻike a nīnau i kāu kauka a kauka paha inā he nīnau kāu. Hiki iā ʻoe ke kipa aku i ka pūnaewele ʻo Food and Drug Administration (FDA) (http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm) a i ʻole pūnaewele o ka mea hana e kiʻi i ka Medication Guide.

Kau ʻia kēia lāʻau no nā hoʻohana ʻē aʻe; e noi i kāu kauka a kauka paha no ka ʻike hou aku.


Ma mua o ka loaʻa ʻana o ka pahu paʻi emapalumab-lzsg,

  • e haʻi i kāu kauka a me kāu kauka lāʻau inā he maʻi ʻoe i ka emapalumab-lzsg, nā lāʻau ʻē aʻe, a i ʻole kekahi o nā mea hana i ka inikū emapalumab-lzsg. E noi i kāu kauka lāʻau a nānā i ke alakaʻi lāʻau no kahi papa inoa o nā mea hoʻohui.
  • e haʻi i kāu kauka inā loaʻa iā ʻoe a i ʻole loaʻa i kekahi ʻano olakino.
  • e haʻi i kāu kauka a me ka mea kauka lāʻau i nā lāʻau lapaʻau, nā wikamina, nā mea hoʻopihapiha, a me nā huahana lāʻau āu e lawe nei a hoʻolālā paha e lawe. Pono paha kāu kauka e hoʻololi i nā kaha o kāu mau lāʻau a nānā pono iā ʻoe no nā hopena ʻaoʻao.
  • e haʻi i kāu kauka inā hāpai ʻoe, hoʻolālā e hāpai, a i ʻole e hānai umauma ana. Inā hāpai ʻoe i ka loaʻa ʻana o ka pahu o emapalumab-lzsg, e kāhea i kāu kauka.
  • pono ʻoe e ʻike i ka hoʻopili ʻana o ka emapalumab-lzsg i kou hiki ke hakakā i ka maʻi mai nā koʻohune, nā mea hoʻomaʻi, a me nā fungi a hoʻonui i ka makaʻu e loaʻa ʻoe i kahi maʻi koʻikoʻi a weliweli paha i ke ola. E haʻi i kāu kauka inā loaʻa pinepine ʻoe i kekahi ʻano maʻi a i ʻole inā manaʻo a manaʻo paha ʻoe he ʻano maʻi paha kāu i kēia manawa. Hoʻopili kēia i nā maʻi liʻiliʻi (e like me nā ʻoki hāmama a i ʻole nā ​​ʻeha), nā maʻi i hiki a hele (e like me ka herpes a i ʻole nā ​​maʻi anuanu), a me nā maʻi maʻi ʻole e hele. Inā ʻoe e ʻike i kekahi o nā ʻōuli ma hope a i ʻole a ma hope koke paha o kou mālama ʻia ʻana me ka pahu ʻana o ka emapalumab-lzsg, e kelepona koke i kāu kauka: fever, sweats, or chills; ʻeha ka ʻili; uā; mucus koko; pokole o ka hanu; ʻeha ka ʻāʻī a paʻakikī paha i ka ale ʻana; mahana, ʻulaʻula, a ʻeha ʻeha a ʻeha paha ma kou kino; pāhoehoe; ʻeha ka ʻōpū; urination pinepine, ʻino, a ʻeha hoʻi; aiʻole nā ​​hōʻailona ʻē aʻe o ka maʻi.
  • pono ʻoe e ʻike i ka loaʻa ʻana o ka hoʻopili ʻana o emapalumab-lzsg e hoʻonui ai i ka makaʻu e hoʻomōhala ʻoe i ka maʻi puʻuwai (TB; kahi maʻi puʻuwai koʻikoʻi), keu hoʻi inā ua loʻohia ʻoe i ka TB akā ʻaʻohe ou ʻōuli o ka maʻi. E haʻi aku i kāu kauka inā loaʻa paha iā ʻoe ka TB, inā ʻoe i noho i kahi ʻāina i maʻa mau ka TB, a i ʻole inā puni ʻoe i kekahi me ka TB. E nānā aku kāu kauka iā ʻoe no ka TB ma mua o ka hoʻomaka ʻana o ka mālama ʻana me ka hoʻopili ʻana o emapalumab-lzsg a mālama paha iā ʻoe no ka TB inā he moʻaukala kāu o TB a i ʻole he TB hana. Inā loaʻa iā ʻoe kekahi o nā ʻōuli o TB a i ʻole ke hoʻomohala i kekahi o kēia mau hōʻailona i kou wā e lapaʻau ai, e kāhea koke aku i kāu kauka: batukū, ʻūlū ʻana i ke koko a i ʻole nā ​​mucus, nāwaliwali a māluhiluhi paha, ka pohō o ke kaumaha, ka nele o ka makemake, nā anuanu, ke kuni, aiʻole ka sweats i ka pō.
  • ʻaʻohe o nā lāʻau āpau me ke kamaʻilio ʻole ʻana i kāu kauka i kou wā e mālama ai me ka hoʻopili ʻana o emapalumab-lzsg a no 4 mau pule ma hope o kāu hopena hope loa.

Inā ʻaʻole haʻi kāu kauka iā ʻoe, e hoʻomau i kāu papaʻai maʻamau.


Hoʻokumu paha ka hopena Emapalumab-lzsg i nā hopena ʻaoʻao. E haʻi i kāu kauka inā koʻikoʻi kekahi o kēia mau ʻōuli a mai hele aku paha:

  • kōpaʻa
  • kahe ka ihu

Hiki i kekahi o nā hopena ʻaoʻao ke koʻikoʻi. Inā ʻoe e ʻike i kekahi o kēia mau ʻōuli a i ʻole nā ​​mea i helu ʻia ma ka ʻaoʻao HOW a me ka ʻĀina KĀNĀWAI, e hooki i ka lawe ʻana i ka pahu emapalumab-lzsg a kāhea koke aku i kāu kauka a i ʻole e kiʻi i ka lāʻau olakino olakino.

  • wikiwiki, lohi, a i ʻole kūpikipikiʻi ʻole
  • hanu wikiwiki
  • ʻūpē mākala
  • numbness a me ka ʻalalā ʻana
  • koko a ʻeleʻele paha, noho aliʻi
  • ka luaʻi ʻana i ke koko a i ʻole nā ​​mea ʻeleʻele e like me ke kahua kope
  • hoʻemi urination
  • pehu i nā lima, ka wāwae, nā kuʻekuʻe wāwae, a me nā wāwae lalo

Hoʻokumu paha ka hoʻopili ʻana o Emapalumab-lzsg i nā hopena ʻē aʻe. Kāhea i kāu kauka inā he pilikia ʻokoʻa kāu i ka lawe ʻana i kēia lāʻau.

Inā ʻoe e ʻike i kahi hopena koʻikoʻi, e hoʻouna ʻoe a i ʻole kāu kauka i kahi hōʻike i ka papahana hōʻike ʻino a MedWatch Adverse Event Food (FDA) ma ka pūnaewele (http://www.fda.gov/Safety/MedWatch) a i ʻole kelepona. 1-800-332-1088).

I ke kumu o ka overdose, e kāhea i ka helpline kaohi lāʻau make ma 1-800-222-1222. Loaʻa ka ʻike ma ka pūnaewele ma https://www.poisonhelp.org/help. Inā ua hina ka mea i hoʻomāinoino ʻia, loaʻa ka hopu ʻana, pilikia i ka hanu ʻana, a i ʻole hiki ʻole ke ala aʻe, e kāhea koke i nā lawelawe kūikawā ma 911.

E mālama i nā manawa a pau me kāu kauka a me ka hale hana. E nānā pinepine kāu kauka i kou kaomi koko a e kauoha i kekahi mau hoʻokolohua lab ma mua a i kou wā o ka mālama ʻana me ka inikū emapalumab-lzsg e nānā i ka pane o kou kino i ka lāʻau.

He mea nui iā ʻoe e mālama i kahi papa inoa i kākau ʻia a me nā lāʻau lapaʻau ʻole (over-the-counter) lāʻau āu e lawe nei, a me nā huahana e like me nā huaora, nā minelala, a i ʻole nā ​​mea hoʻopiliʻai aʻe. Pono ʻoe e lawe i kēia papa inoa me ʻoe i kēlā me kēia manawa ke kipa ʻoe i ke kauka a i ʻole inā ʻae ʻia ʻoe i kahi haukapila. He ʻike nui nō hoʻi ia e lawe pū me ʻoe inā pilikia ʻo ka pilikia.

  • Gamifant®
Nānā Hou - 05/15/2019

E HōʻOia E Heluhelu

Ka Hōʻino Ligament Posterior Cruciate

Ka Hōʻino Ligament Posterior Cruciate

He aha ka ʻeha po terior Cruciate Ligament?ʻO ka ligament cruciate po terior (PCL) ka ligament ikaika loa ma ka hui kuli. Mānoanoa nā ligament, nā paʻa paʻa o nā mea e hoʻopili i ka iwi i ka iwi. Hol...
I ka manawa a pehea e hoʻopau ai i kahi koi Medicare i faila ʻia e ʻoe

I ka manawa a pehea e hoʻopau ai i kahi koi Medicare i faila ʻia e ʻoe

Hiki iā ʻoe ke kāhea iā Medicare e kāpae i kahi hoʻopiʻi āu i faila ai.E faila maʻamau kāu kauka a mea hāʻawi paha iā ʻoe.E faila paha ʻoe i kāu hoʻopiʻi ponoʻī inā ʻaʻole a hiki ʻole i kāu kauka.Ke h...